Spearhead Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Spearhead Capital Advisors's AMGN Position: Q3 2022 in Review
Spearhead Capital Advisors reduced its Amgen (AMGN) stake by 88% in Q3 2022, selling an estimated $8.11M and leaving 4,417 shares worth $996K. The position accounts for 1.08% of the portfolio, ranked #29.
Spearhead Capital Advisors first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $11.1M in Q1 2022. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Spearhead Capital Advisors held 4,417 shares of Amgen worth $996K as of Q3 2022.
- Spearhead Capital Advisors sold 33,477 Amgen shares in Q3 2022, an estimated $8.11M.
- Amgen made up 1.08% of Spearhead Capital Advisors's portfolio in Q3 2022, its #29 holding.
- Spearhead Capital Advisors first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
- Spearhead Capital Advisors's Amgen position peaked at $11.1M in Q1 2022.
- 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.